BSE Live
Jan 23, 16:01Prev. Close
1431.95
Open Price
1437.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:40Prev. Close
1434.90
Open Price
1454.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1379.90 (50)
| Balance Sheet of Hester Biosciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | |
| Total Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | |
| Reserves and Surplus | 194.57 | 170.93 | 137.57 | 113.58 | 91.81 | |
| Total Reserves and Surplus | 194.57 | 170.93 | 137.57 | 113.58 | 91.81 | |
| Total Shareholders Funds | 203.08 | 179.44 | 146.08 | 122.09 | 100.32 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 7.45 | 11.37 | 14.61 | 18.66 | 13.02 | |
| Deferred Tax Liabilities [Net] | 8.29 | 10.09 | 7.32 | 3.55 | 8.03 | |
| Other Long Term Liabilities | 0.15 | 0.05 | 0.05 | 0.15 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 15.89 | 21.51 | 21.98 | 22.36 | 21.05 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 31.80 | 20.94 | 24.19 | 17.51 | 21.04 | |
| Trade Payables | 13.61 | 8.05 | 7.85 | 7.47 | 5.84 | |
| Other Current Liabilities | 12.37 | 10.05 | 10.38 | 8.96 | 7.48 | |
| Short Term Provisions | 0.44 | 0.26 | 0.00 | 0.04 | 3.09 | |
| Total Current Liabilities | 58.22 | 39.30 | 42.43 | 33.99 | 37.45 | |
| Total Capital And Liabilities | 277.19 | 240.24 | 210.49 | 178.44 | 158.82 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 96.08 | 100.12 | 65.95 | 60.00 | 60.90 | |
| Intangible Assets | 0.39 | 0.48 | 0.65 | 0.71 | 0.67 | |
| Capital Work-In-Progress | 0.87 | 0.42 | 30.47 | 21.29 | 10.47 | |
| Other Assets | 0.29 | 0.21 | 0.14 | 0.14 | 0.00 | |
| Fixed Assets | 97.64 | 101.23 | 97.21 | 82.14 | 72.04 | |
| Non-Current Investments | 40.67 | 28.22 | 14.48 | 8.60 | 8.67 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 5.09 | 5.47 | 4.44 | 4.03 | 10.93 | |
| Other Non-Current Assets | 10.61 | 5.92 | 5.23 | 8.85 | 0.00 | |
| Total Non-Current Assets | 154.01 | 140.84 | 121.36 | 103.63 | 91.64 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 60.43 | 48.50 | 38.70 | 33.07 | 33.62 | |
| Trade Receivables | 44.76 | 32.67 | 31.94 | 26.71 | 26.24 | |
| Cash And Cash Equivalents | 5.19 | 2.49 | 11.95 | 11.48 | 5.26 | |
| Short Term Loans And Advances | 0.10 | 0.26 | 0.07 | 0.00 | 2.07 | |
| OtherCurrentAssets | 12.70 | 15.48 | 6.47 | 3.56 | 0.00 | |
| Total Current Assets | 123.18 | 99.40 | 89.13 | 74.81 | 67.18 | |
| Total Assets | 277.19 | 240.24 | 210.49 | 178.44 | 158.82 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 107.06 | 29.36 | 0.00 | 4.86 | 1.58 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 4.48 | 1.60 | 3.30 | 2.38 | |
| Stores, Spares And Loose Tools | 1.17 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 1.17 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.64 | 0.09 | 0.55 | 2.38 | 0.16 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 2.36 | 2.81 | 0.88 | 1.15 | 0.88 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | 0.13 | 0.08 | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 20.18 | 11.99 | 11.28 | 13.46 | 9.27 | |
| Other Earnings | 16.40 | 0.83 | 2.27 | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 2.84 | 2.84 | 2.84 | 2.84 | 2.84 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 40.67 | 28.22 | 14.48 | 8.60 | 8.67 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y